Altria Group Inc. (MO)
Stock · NYSE · Health Care
$75.1as of 10/16/2026
Price chart
Active signals
MO Signal Track Record
How signals performed across all stocks →What MO's price did in the 20 trading sessions after each past signal, compared with any 20-session window over the same period.
| Signal | Times | Median 20-session return | Higher after 20 sessions | Last signal |
|---|---|---|---|---|
| Volume Spike | 30 | +2.1% | 63% | September 18, 2026 |
| 200-Day Moving Average TouchActive now | 24 | +0.5% | 54% | October 1, 2026 |
| Bollinger Band BreakoutActive now | 21 | +2.4% | 62% | October 8, 2026 |
| Bollinger Band Breakdown | 15 | +1.4% | 67% | September 30, 2026 |
| Any 20-session window (baseline) | +1.1% | 60% |
Computed by MarketWall from daily closing prices since May 18, 2022. Returns are close-to-close and don't include dividends. Past results describe what happened before; they are not a forecast and not investment advice.
About MO
Altria Group, Inc., through its subsidiaries, manufactures and sells smokeable and oral tobacco products in the United States. It offers cigarettes primarily under the Marlboro brand; large cigars and pipe tobacco under the Black & Mild brand; moist smokeless tobacco and oral tobacco products under the Copenhagen, Skoal, Red Seal, and Husky brands; oral nicotine pouches under the on! brand; and e-vapor products under…
- Sector
- Health Care
- Industry
- Medicinal Chemicals and Botanical Products
- Employees
- 5,900
- Website
- www.altria.com/
Fundamentals
- 1-day range
- $74.5$74.99
- Market cap
- $113.13B
- P/E (trailing)
- 15.48
- P/E (forward)
- 12.77
- EPS (trailing)
- $4.76
- Dividend yield
- 9.45%
- Beta
- 0.51
- Avg. volume
- 8.61M
- Ex-dividend date
- September 15, 2026
- Dividend pay date
- October 9, 2026
How Altria Group Inc. Makes Money
Where the revenue actually goes — FY2025 annual results
Source: 10-K filed Feb 25, 2026 · via SEC EDGAR / Finnhub
Forecasts
11 analyst ratings
Altria Group Inc. Competitors
Chosen by industry and closest market cap.
- MOAltria Group Inc.$75.11▲ 1.72%Market cap $113.13BP/E 15.48$54.7$77.06
- BTIBritish American Tobacco Industries p.l.c. Common Stock ADR$60▲ 3.45%Market cap $127.32BP/E 14.22$3,718$5,004
- DFTXDefinium Therapeutics Inc. Common Shares$32.1▼ 6.30%Market cap $5.03BP/E —$10.47$49.7
- RLXRLX Technology Inc. American Depositary Shares each representing the right to receive one (1) Class A ordinary share$1.7▼ 0.58%Market cap $3.08BP/E 14.19$1.65$2.6
- RGCRegencell Bioscience Holdings Limited Ordinary Shares$9.59▲ 0.74%Market cap $2.70BP/E —$4.51$69
- TRLVTrulieve Cannabis Corp. Subordinate Voting Shares$10.01▼ 2.82%Market cap $1.73BP/E —$7.82$12.93
- CRONCronos Group Inc. Common Share$3.21▲ 0.31%Market cap $1.16BP/E 16.88$3.23$4.99
| Symbol | Market cap | P/E ratio | Price | 1D | 52-week range |
|---|---|---|---|---|---|
| MO Altria Group Inc. | $113.13B | 15.48 | $75.11 | ▲ 1.72% | $54.7$77.06 |
| BTI British American Tobacco Industries p.l.c. Common Stock ADR | $127.32B | 14.22 | $60 | ▲ 3.45% | $3,718$5,004 |
| DFTX Definium Therapeutics Inc. Common Shares | $5.03B | — | $32.1 | ▼ 6.30% | $10.47$49.7 |
| RLX RLX Technology Inc. American Depositary Shares each representing the right to receive one (1) Class A ordinary share | $3.08B | 14.19 | $1.7 | ▼ 0.58% | $1.65$2.6 |
| RGC Regencell Bioscience Holdings Limited Ordinary Shares | $2.70B | — | $9.59 | ▲ 0.74% | $4.51$69 |
| TRLV Trulieve Cannabis Corp. Subordinate Voting Shares | $1.73B | — | $10.01 | ▼ 2.82% | $7.82$12.93 |
| CRON Cronos Group Inc. Common Share | $1.16B | 16.88 | $3.21 | ▲ 0.31% | $3.23$4.99 |
P/E shows — for peers not currently carrying a live signal of their own.
Latest news
- 5 Relatively Secure And Cheap Dividend Stocks, Yields Up To 8% Plus (October 2026)SeekingAlpha · 10/10/2026
- Treasury Bills or Dividend Stocks? The Retirement Income Math May Surprise YouYahoo · 10/9/2026
- How to Turn $75,000 Into $7,000 in Annual Passive IncomeYahoo · 10/9/2026
- Want Lifetime Passive Income? Put $100,000 Into These Dividend StocksYahoo · 10/8/2026
- Ready to Retire and Want $7,500 a Year in Passive Income? Invest $25,000 in Each of These 5 Dividend StocksYahoo · 10/8/2026
- 3 US Dividend Stocks For Higher Rates Including Verizon StockYahoo · 10/8/2026
- Altria (MO) Rises As Market Takes a Dip: Key FactsYahoo · 10/7/2026
- 2 Reasons to Like MO and 1 to Stay SkepticalYahoo · 10/7/2026
- 'U.S. Regulators Plan Major Move To Speed Authorizations Of Vapes, Tobacco Pouches; Move Comes Despite Lawmakers Voicing Concern About Recent Flavor Approvals' - WSJ Exclusivebenzinga · 9/23/2026
Insider Activity
Insider Actions →- KATHRYN B. McQUADE · September 9, 2026 · Buy1.5K @ $67.62
- Ellen R. Strahlman · May 26, 2026 · Sale2.0K @ $72.56
- Ennis Debra J. Kelly · May 26, 2026 · Sale5.8K @ $72.25
- KATHRYN B. McQUADE · May 14, 2026 · Grant4.7K
- Ian L.T. Clarke · May 14, 2026 · Grant2.6K
- Robert Matthews Davis · May 14, 2026 · Grant2.6K
- Richard S. Stoddart · May 14, 2026 · Grant2.6K
- Marjorie Mary Connelly · May 14, 2026 · Grant2.6K
- Ellen R. Strahlman · May 14, 2026 · Grant2.6K
- Virginia E. Shanks · May 14, 2026 · Grant2.6K
- Ennis Debra J. Kelly · May 14, 2026 · Grant2.6K
- Mario Max Yzaguirre · May 14, 2026 · Grant2.6K
- Salvatore Mancuso · May 13, 2026 · Grant40.6K
Institutional Ownership
March 31, 2026
- Total shares held
- 986.99M
- Total value held
- $63.39B
- Institutional holders
- 2441
- Unknown124.75M
- Unknown108.84M
- Unknown71.79M
- Unknown54.28M
- Unknown47.02M
- Unknown25.68M
- Unknown24.46M
- Unknown23.84M
- Unknown21.50M
- Unknown18.42M
See the full, filterable feed with live charts on the MarketWall dashboard.
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 17, 2026
Altria Stock Rises Amid Broader Market Dip
Altria shares moved higher even as the broader market slipped, drawing attention to its 9.45% dividend yield. Recent coverage highlights its status as a top income generator in the S&P 500, though analysts note the stock price has lagged behind its peers. The company's valuation remains below the average analyst target, with a trailing P/E of 15.5.
Altria Stock Rises Amid Broader Market Dip. Altria shares moved higher even as the broader market slipped, drawing attention to its 9.45% dividend yield. Recent coverage highlights its status as a top income generator in the S&P 500, though analysts note the stock price has lagged behind its peers. The company's valuation remains below the average analyst target, with a trailing P/E of 15.5.